Annual SG&A
$161.70 M
+$37.65 M+30.35%
31 December 2023
Summary:
ANI Pharmaceuticals annual selling, general & administrative expenses is currently $161.70 million, with the most recent change of +$37.65 million (+30.35%) on 31 December 2023. During the last 3 years, it has risen by +$96.71 million (+148.82%). ANIP annual SG&A is now at all-time high.ANIP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$79.08 M
+$26.25 M+49.70%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly selling, general & administrative expenses is currently $79.08 million, with the most recent change of +$26.25 million (+49.70%) on 30 September 2024. Over the past year, it has increased by +$37.07 million (+88.24%). ANIP quarterly SG&A is now at all-time high.ANIP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$297.08 M
-$8.72 M-3.02%
30 September 2024
Summary:
ANI Pharmaceuticals TTM selling, general & administrative expenses is currently -$297.08 million, with the most recent change of -$8.72 million (-3.02%) on 30 September 2024. Over the past year, it has dropped by -$447.51 million (-297.50%). ANIP TTM SG&A is now -521.60% below its all-time high of $224.38 million, reached on 30 September 2024.ANIP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.4% | +88.2% | -297.5% |
| 3 y3 years | +148.8% | +360.3% | -537.2% |
| 5 y5 years | +267.0% | +450.8% | -638.1% |
ANIP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +148.8% | at high | +360.3% | -468.2% | +21.1% |
| 5 y | 5 years | at high | +267.0% | at high | +477.9% | -521.6% | +21.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | -521.6% | +69.3% |
ANI Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $79.08 M(+49.7%) | $224.38 M(+19.8%) |
| June 2024 | - | $52.82 M(+10.0%) | $187.31 M(+8.1%) |
| Mar 2024 | - | $48.02 M(+8.0%) | $173.25 M(+7.1%) |
| Dec 2023 | $161.70 M(+30.4%) | $44.46 M(+5.8%) | $161.70 M(+7.5%) |
| Sept 2023 | - | $42.01 M(+8.4%) | $150.42 M(+8.6%) |
| June 2023 | - | $38.76 M(+6.3%) | $138.50 M(+5.2%) |
| Mar 2023 | - | $36.47 M(+9.9%) | $131.69 M(+6.2%) |
| Dec 2022 | $124.04 M(+47.2%) | $33.19 M(+10.3%) | $124.04 M(+2.0%) |
| Sept 2022 | - | $30.08 M(-5.9%) | $121.56 M(+11.9%) |
| June 2022 | - | $31.96 M(+10.9%) | $108.66 M(+13.8%) |
| Mar 2022 | - | $28.82 M(-6.2%) | $95.52 M(+13.3%) |
| Dec 2021 | $84.29 M(+29.7%) | $30.71 M(+78.7%) | $84.29 M(+24.0%) |
| Sept 2021 | - | $17.18 M(-8.7%) | $67.95 M(+2.2%) |
| June 2021 | - | $18.82 M(+7.0%) | $66.50 M(-3.5%) |
| Mar 2021 | - | $17.59 M(+22.4%) | $68.89 M(+6.0%) |
| Dec 2020 | $64.99 M(+16.4%) | $14.37 M(-8.6%) | $64.99 M(+0.5%) |
| Sept 2020 | - | $15.72 M(-25.9%) | $64.64 M(+2.2%) |
| June 2020 | - | $21.21 M(+55.0%) | $63.27 M(+12.5%) |
| Mar 2020 | - | $13.68 M(-2.4%) | $56.24 M(+0.7%) |
| Dec 2019 | $55.84 M(+26.7%) | $14.01 M(-2.4%) | $55.84 M(+1.2%) |
| Sept 2019 | - | $14.36 M(+1.2%) | $55.20 M(+4.9%) |
| June 2019 | - | $14.19 M(+6.8%) | $52.62 M(+8.7%) |
| Mar 2019 | - | $13.28 M(-0.7%) | $48.39 M(+9.8%) |
| Dec 2018 | $44.06 M(+39.5%) | $13.38 M(+13.7%) | $44.06 M(+11.3%) |
| Sept 2018 | - | $11.77 M(+18.1%) | $39.57 M(+10.5%) |
| June 2018 | - | $9.96 M(+11.2%) | $35.83 M(+7.8%) |
| Mar 2018 | - | $8.96 M(+0.8%) | $33.24 M(+5.3%) |
| Dec 2017 | $31.58 M(+13.5%) | $8.88 M(+10.8%) | $31.58 M(+5.0%) |
| Sept 2017 | - | $8.02 M(+8.7%) | $30.06 M(+3.8%) |
| June 2017 | - | $7.38 M(+1.2%) | $28.97 M(-0.8%) |
| Mar 2017 | - | $7.29 M(-1.0%) | $29.22 M(+5.0%) |
| Dec 2016 | $27.83 M(+31.5%) | $7.37 M(+6.4%) | $27.83 M(+7.4%) |
| Sept 2016 | - | $6.93 M(-9.2%) | $25.91 M(+6.3%) |
| June 2016 | - | $7.63 M(+29.2%) | $24.39 M(+9.3%) |
| Mar 2016 | - | $5.90 M(+8.2%) | $22.31 M(+5.4%) |
| Dec 2015 | $21.16 M(+18.0%) | $5.46 M(+1.0%) | $21.16 M(+3.5%) |
| Sept 2015 | - | $5.40 M(-2.7%) | $20.44 M(+7.0%) |
| June 2015 | - | $5.55 M(+16.8%) | $19.10 M(+0.6%) |
| Mar 2015 | - | $4.75 M(+0.2%) | $18.98 M(+5.8%) |
| Dec 2014 | $17.93 M(+9.4%) | $4.74 M(+16.9%) | $17.93 M(+7.9%) |
| Sept 2014 | - | $4.06 M(-25.3%) | $16.62 M(+3.6%) |
| June 2014 | - | $5.43 M(+46.7%) | $16.04 M(-9.8%) |
| Mar 2014 | - | $3.70 M(+8.1%) | $17.78 M(+10.9%) |
| Dec 2013 | $16.39 M(+99.1%) | $3.43 M(-1.5%) | $16.03 M(+3.4%) |
| Sept 2013 | - | $3.48 M(-51.5%) | $15.50 M(+14.2%) |
| June 2013 | - | $7.17 M(+268.0%) | $13.57 M(+62.6%) |
| Mar 2013 | - | $1.95 M(-32.8%) | $8.35 M(+1.4%) |
| Dec 2012 | $8.23 M(+17.9%) | $2.90 M(+87.6%) | $8.23 M(+16.7%) |
| Sept 2012 | - | $1.55 M(-20.6%) | $7.05 M(-1.8%) |
| June 2012 | - | $1.95 M(+6.4%) | $7.18 M(-0.6%) |
| Mar 2012 | - | $1.83 M(+6.3%) | $7.22 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $6.98 M(+17.5%) | $1.72 M(+2.9%) | $6.98 M(+9.8%) |
| Sept 2011 | - | $1.68 M(-15.8%) | $6.36 M(+2.3%) |
| June 2011 | - | $1.99 M(+24.8%) | $6.22 M(+7.8%) |
| Mar 2011 | - | $1.59 M(+45.0%) | $5.77 M(-2.9%) |
| Dec 2010 | $5.94 M(+10.5%) | $1.10 M(-28.4%) | $5.94 M(-8.2%) |
| Sept 2010 | - | $1.53 M(-0.4%) | $6.47 M(+0.4%) |
| June 2010 | - | $1.54 M(-12.8%) | $6.44 M(+5.4%) |
| Mar 2010 | - | $1.77 M(+8.4%) | $6.11 M(+13.7%) |
| Dec 2009 | $5.37 M(-9.9%) | $1.63 M(+8.2%) | $5.37 M(+0.5%) |
| Sept 2009 | - | $1.51 M(+24.6%) | $5.35 M(+1.3%) |
| June 2009 | - | $1.21 M(+17.5%) | $5.28 M(-6.8%) |
| Mar 2009 | - | $1.03 M(-35.8%) | $5.67 M(-5.0%) |
| Dec 2008 | $5.96 M(+37.6%) | $1.60 M(+11.5%) | $5.96 M(+8.8%) |
| Sept 2008 | - | $1.44 M(-9.7%) | $5.48 M(+8.1%) |
| June 2008 | - | $1.59 M(+20.2%) | $5.07 M(+5.6%) |
| Mar 2008 | - | $1.33 M(+18.4%) | $4.80 M(+7.5%) |
| Dec 2007 | $4.33 M(-38.3%) | $1.12 M(+9.0%) | $4.46 M(-31.0%) |
| Sept 2007 | - | $1.03 M(-22.4%) | $6.47 M(+14.5%) |
| June 2007 | - | $1.32 M(+33.4%) | $5.65 M(-0.1%) |
| Mar 2007 | - | $992.40 K(-68.2%) | $5.65 M(-19.5%) |
| Dec 2006 | $7.03 M(+130.3%) | $3.12 M(+1383.0%) | $7.03 M(+47.8%) |
| Sept 2006 | - | $210.60 K(-84.1%) | $4.75 M(-9.4%) |
| June 2006 | - | $1.33 M(-43.8%) | $5.25 M(+11.8%) |
| Mar 2006 | - | $2.36 M(+178.0%) | $4.69 M(+53.8%) |
| Dec 2005 | $3.05 M(-1.0%) | $849.90 K(+20.6%) | $3.05 M(+0.0%) |
| Sept 2005 | - | $705.00 K(-9.1%) | $3.05 M(+7.7%) |
| June 2005 | - | $775.20 K(+7.6%) | $2.83 M(+1.1%) |
| Mar 2005 | - | $720.50 K(-15.1%) | $2.80 M(-9.1%) |
| Dec 2004 | $3.08 M(+32.4%) | $848.60 K(+73.8%) | $3.08 M(+5.8%) |
| Sept 2004 | - | $488.30 K(-34.3%) | $2.91 M(+0.2%) |
| June 2004 | - | $743.20 K(-25.7%) | $2.90 M(+2.8%) |
| Mar 2004 | - | $1.00 M(+47.3%) | $2.82 M(+21.4%) |
| Dec 2003 | $2.33 M(+31.8%) | $678.80 K(+41.1%) | $2.33 M(+13.6%) |
| Sept 2003 | - | $481.10 K(-27.6%) | $2.05 M(+3.4%) |
| June 2003 | - | $664.90 K(+32.4%) | $1.98 M(+9.6%) |
| Mar 2003 | - | $502.30 K(+25.3%) | $1.81 M(+2.4%) |
| Dec 2002 | $1.77 M(-23.2%) | $400.80 K(-3.1%) | $1.77 M(-10.8%) |
| Sept 2002 | - | $413.80 K(-15.9%) | $1.98 M(-13.4%) |
| June 2002 | - | $491.90 K(+7.1%) | $2.29 M(-0.3%) |
| Mar 2002 | - | $459.10 K(-25.4%) | $2.29 M(-0.3%) |
| Dec 2001 | $2.30 M(+36.9%) | $615.20 K(-14.6%) | $2.30 M(-1.7%) |
| Sept 2001 | - | $720.50 K(+44.7%) | $2.34 M(+15.0%) |
| June 2001 | - | $498.00 K(+7.1%) | $2.03 M(+10.4%) |
| Mar 2001 | - | $465.10 K(-28.9%) | $1.84 M(+9.8%) |
| Dec 2000 | $1.68 M(+96.7%) | $653.90 K(+57.1%) | $1.68 M(+63.8%) |
| Sept 2000 | - | $416.20 K(+35.4%) | $1.02 M(+68.4%) |
| June 2000 | - | $307.30 K(+2.0%) | $608.50 K(+32.7%) |
| Mar 2000 | - | $301.20 K(+91.2%) | $458.70 K(+191.2%) |
| Dec 1999 | $853.40 K(-23.3%) | - | - |
| June 1999 | - | $157.50 K | $157.50 K |
| Dec 1998 | $1.11 M | - | - |
FAQ
- What is ANI Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual SG&A year-on-year change?
- What is ANI Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly SG&A year-on-year change?
- What is ANI Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM SG&A year-on-year change?
What is ANI Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of ANIP is $161.70 M
What is the all time high annual SG&A for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual selling, general & administrative expenses is $161.70 M
What is ANI Pharmaceuticals annual SG&A year-on-year change?
Over the past year, ANIP annual selling, general & administrative expenses has changed by +$37.65 M (+30.35%)
What is ANI Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of ANIP is $79.08 M
What is the all time high quarterly SG&A for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $79.08 M
What is ANI Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, ANIP quarterly selling, general & administrative expenses has changed by +$37.07 M (+88.24%)
What is ANI Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of ANIP is -$297.08 M
What is the all time high TTM SG&A for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM selling, general & administrative expenses is $224.38 M
What is ANI Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, ANIP TTM selling, general & administrative expenses has changed by -$447.51 M (-297.50%)